anti-SLC29A1 antibody product blog
Tags: Antibody; Polyclonal Antibody; anti-SLC29A1 antibody; SLC29A1; Phospho-ENT1 (Slc29a1) (S254);
The SLC29A1 slc29a1 (Catalog #MBS9214821) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Phospho-ENT1 (Slc29a1) (S254) Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s Phospho-ENT1 (Slc29a1) (S254) can be used in a range of immunoassay formats including, but not limited to, Dot Blot (DB), ELISA (EIA).DB~~1:500. Researchers should empirically determine the suitability of the SLC29A1 slc29a1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The SLC29A1 slc29a1 product has the following accession number(s) (GI #118582260) (NCBI Accession #NP_001071642.1) (Uniprot Accession #Q99808). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Phospho-ENT1 (Slc29a1) (S254) Antibody with the following immunoassay(s):
Dot Blot (DB) (Dot blot analysis of anti-Phospho-ENT1(Slc29a1)-pS254 Antibody on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.5ug per ml.)
ENT1 is a member of the equilibrative nucleoside transporter family. The protein is categorized as an equilibrative (as opposed to concentrative) transporter that is sensitive to inhibition by nitrobenzylthioinosine (NBMPR). Nucleoside transporters are required for nucleotide synthesis in cells that lack de novo nucleoside synthesis pathways, and are also necessary for the uptake of cytotoxic nucleosides used for cancer and viral chemotherapies.
Antigen Type: Synthetic Peptide. Antigen Source: HUMAN. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing SLC29A1 are readily searchable from our website. Different antibodies against the same target such as SLC29A1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Adenocarcinoma, Breast Neoplasms, Inflammation, Liver Diseases, Lung Neoplasms, Necrosis, Neoplasm Metastasis, Neoplasms, Experimental, Nervous System Diseases, Pancreatic Neoplasms are some of the diseases may be linked to Phospho-ENT1 (Slc29a1) (S254) Antibody. SLC29A1 also interacts with the following gene(s): ADORA1, DCK, NOS3, SLC1A2, SLC28A1, SLC28A2, SLC28A3, TGFB1. The following patways have been known to be associated with this gene. Blood, Bone, Brain, Heart, Kidney, Liver, Lung, Muscle, Pancreas, Vascular tissues are correlated with this protein.